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The human papillomavirus (HPV) E2 protein is a multifunctional protein essential for the control
of virus gene expression, genome replication and persistence. E2 is expressed throughout the
differentiation-dependent virus life cycle and is functionally regulated by association with
multiple viral and cellular proteins. Here, we show for the first time to our knowledge that
HPV16 E2 directly associates with the major capsid protein L1, independently of other viral or
cellular proteins. We have mapped the L1 binding region within E2 and show that the a-2
helices within the E2 DNA-binding domain mediate L1 interaction. Using cell-based assays, we
show that co-expression of L1 and E2 results in enhanced transcription and virus origin-
dependent DNA replication. Upon co-expression in keratinocytes, L1 reduces nucleolar
association of E2 protein, and when co-expressed with E1 and E2, L1 is partially recruited to
viral replication factories. Furthermore, co-distribution of E2 and L1 was detected in the nuclei
of upper suprabasal cells in stratified epithelia of HPV16 genome-containing primary human
keratinocytes. Taken together, our findings suggest that the interaction between E2 and L1 is
important for the regulation of E2 function during the late events of the HPV life cycle.
Received 15 January 2015
Accepted 23 April 2015
INTRODUCTION
Human papillomaviruses (HPVs) are small, double-
stranded DNA viruses that infect epithelia in multiple
areas of the body, causing benign warts or, in some cases,
cancer. Infection is established in the undifferentiated
basal layer of the epithelia, and expression of the early
genes E6, E7, E1 and E2 is initiated from the early promoter
(P97 in HPV16). The combined expression of the E6 and
E7 oncoproteins delays cell cycle exit and cellular differen-
tiation, which are necessary for replication and amplifica-
tion of viral genomes (Doorbar et al., 2012). The E2
protein is a specific DNA-binding protein that is important
for the replication of HPV genomes, by recruiting the viral
helicase E1 to the origin of replication (Ori) (Sanders &
Stenlund, 2001). In addition, E2 controls transcription of
the early genes by association with the transcriptional
enhancer immediately upstream of the early promoter
(Bernard et al., 1989; Kovelman et al., 1996).
The E2 protein is folded into three distinct domains; the
N-terminal transactivation domain, which is separated
from the C-terminal DNA-binding and dimerization
domain (DBD) by a disordered and flexible hinge region
(Giri & Yaniv, 1988). E2 does not possess enzymic activity,
but by association with a plethora of viral and cellular pro-
teins, co-ordinates virus genome replication, transcrip-
tional regulation, viral genome partitioning and cell cycle
control (reviewed by McBride, 2013).
The limited number of proteins encoded within the 8 kb
HPV genome forces an unusual economy; not only do
most HPV proteins have multiple roles in the virus life
cycle, but associations between HPV proteins increase the
functional significance of the differentiation-dependent
timing of viral protein expression. Previous work has
demonstrated an association between E2 and the early pro-
teins E1, E6 and E7. Interaction with E1 is important for
viral genome replication (Mohr et al., 1990), while associ-
ation with E7 inhibits E7-dependent transformation
(Gammoh et al., 2006). The interaction between E2 and
E6 causes relocalization of both proteins to nuclear speckles
and a corresponding decrease in E2-dependent virus repli-
cation. E6 function is also affected by co-expression of E2,
as demonstrated by a reduction in degradation of target
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proteins (Grm et al., 2005). Concomitant with activation of
late gene expression in the virus life cycle, E2 protein
accumulates (Xue et al., 2010). This is thought to result
in repression of the E6- and E7-encoding early transcripts,
promoting cellular differentiation and production of late
transcripts (Bouvard et al., 1994; Steger & Corbach, 1997;
Thierry & Yaniv, 1987). E2 also forms a complex with
E1^E4 and L2, which are expressed in the late stages of
the life cycle. Interaction with E1^E4 stabilizes E2, poten-
tially contributing to E2 protein accumulation (Davy
et al., 2009). Association of E2 and the minor capsid pro-
tein L2 facilitates recruitment of E2 to ND10 bodies (also
known as PML-oncogenic domains) within the nucleus
(Day et al., 1998) and repression of E2-dependent
transcription (Heino et al., 2000). It is hypothesized that
interaction of E2 with L2 is important for virus genome
encapsidation.
At the end of the life cycle, newly synthesized L1 protein is
imported into the nucleus as pentameric capsomeres
through the karyopherin a2b1 heterodimer, where virus
assembly takes place (Bird et al., 2008; Merle et al.,
1999). The mature virion contains the major capsid pro-
tein, L1, and the minor protein, L2. L1 and L2 interact
and, although the binding interface between L1 and L2 is
poorly defined, studies indicate that L2 binds to hydro-
phobic residues of L1 and is therefore positioned in the
central cavity of L1 pentamers (Finnen et al., 2003; Lowe
et al., 2008). Sequences at the C terminus of L1 are import-
ant for non-specific interaction with DNA (Li et al., 1997)
and it has been suggested that key features in the L1 protein
resemble histone chaperone proteins and that L1 may bind
histones to facilitate genome packaging (Buck et al., 2013).
In this study, we hypothesized that E2 associates with the
major capsid protein, L1, and that this interaction is
important in regulating E2 function in the late stages of
the virus life cycle. We have confirmed this interaction in
human keratinocytes and show for the first time that L1
co-operates with E2 to enhance transcription activation
and virus DNA replication. Furthermore, we demonstrate
that L1 affects the localization of E2 protein and that L1
is partially recruited to E1/E2 viral replication foci.
We hypothesize therefore that L1 contributes to the regu-
lation of E2 in the virus life cycle.
RESULTS
In silico analysis of E2 and L1 interaction
The interaction between E2 and L1 was computationally
analysed and the best-docked complexes were obtained
based on energy minimization. These complexes were
further analysed to determine the residues that were in
close proximity at the predicted binding interface (Fig. 1).
Based on consensus from 21 best-docked complexes, it was
concluded that aa 335–365 of E2 have a high likelihood of
association with L1. These residues make up the a-2 helix
of the E2 DBD. The region of L1 predicted to bind to E2
was within an external loop between aa 250 and aa 290,
which is also predicted to bind L2 (Lowe et al., 2008).
Characterization of the interaction between
HPV16 E2 and L1
To determine whether E2 associates with L1 in a cell-based
assay, co-immunoprecipitation experiments were carried
out. HPV-negative cervical carcinoma-derived C33a cells
were co-transfected with HPV16 E2 and codon-optimized
L1 expression constructs alone or in combination, and the
proteins immunoprecipitated with E2-specific antibody or
isotype control (IgG). L1 protein was robustly co-
immunoprecipitated with E2-specifc antibody when
co-expressed with E2 and only a minimal amount of L1 pro-
tein was non-specifically immunoprecipiated in the absence
of E2 protein, demonstrating specificity of the assay
(Fig. 2a). We also performed the reverse co-immunopre-
cipitation, where complexes were immunoprecipitated
with L1 protein-specific antibody and co-precipitated E2
was detected by Western blotting (Fig. 2a).
To further test our in silico analysis of the E2–L1 binding
surfaces, domain mapping experiments using full-length
and truncated glutathione-S-transferase (GST)-tagged E2
proteins were carried out. GST-tagged E2 proteins bound
to glutathione-agarose beads were incubated with purified
L1 capsomeres. As expected, L1 capsomeres bound with
high affinity to full-length E2 while no binding was
observed to the affinity resin alone or the GST-bound
resin (Fig. 2b). Domain mapping revealed that the L1 bind-
ing site within E2 exists in the C-terminal transactivation
domain as aa 202–365 bound L1 capsomeres, while aa
1–257 did not. Furthermore, aa 306–365 at the extreme
C-terminal region of E2 bound L1 protein, while aa
202–306 were unable to bind L1. The L1-binding region
between aa 306 and aa 365 is outside the DNA-binding sur-
face of E2 (a-1 helices) but contains the a-2 helices that
were predicted to bind L1 in our in silico analysis (Figs 1
and 2c), providing evidence that the binding model may
reflect the true binding interface. These binding experi-
ments demonstrate a previously uncharacterized direct
interaction between HPV16 E2 and L1 proteins that
could have important implications for the virus life cycle.
As both L1 and E2 proteins are known to bind to DNA
(Dell et al., 2003; Scha¨fer et al., 2002), and the L1 binding
surface on E2 was within the C-terminal DNA-binding
domain but outside the specific DNA-binding helices of
E2, it is possible that the interaction is mediated by both
proteins simultaneously associating with contaminating
DNA. We therefore repeated co-immunoprecipitation
experiments in the presence of ethidium bromide, which
intercalates with DNA and prevents protein–DNA inter-
actions. Incubation of the protein lysates with ethidium
bromide did not affect the ability of E2 and L1 to form a
complex (Fig. 2d). It is therefore unlikely that this novel
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protein–protein interaction is mediated by interaction
with? DNA.
L1 stimulates E2-dependent transcription
activation and replication
To determine whether the association between HPV16 E2
and L1 alters E2 function, the ability of E2 to activate tran-
scription in the presence of L1 was analysed. C33a cells
were transfected with a luciferase reporter plasmid contain-
ing six E2 binding sites upstream of a thymidine kinase
promoter, which controls expression of firefly luciferase,
along with full-length E2 and increasing amounts of L1
plasmid. Protein expression was confirmed by Western
blotting (Fig. 3a). Expression of E2 alone resulted in an
over 50-fold activation of transcription from the reporter
plasmid (Fig. 3b). Expression of L1 protein alone resulted
in a small increase in transcription in comparison with
reporter alone, but this did not reach significance
(P50.06). Interestingly, co-expression of L1 with E2
resulted in a dose-dependent increase in luciferase activity,
indicating that E2 and L1 co-operate to stimulate transcrip-
tional activation.
The binding assays shown in Fig. 2b demonstrated that
L1 protein associates with the C-terminal DNA-binding
domain of E2. We therefore repeated the transcription
assay using the truncated E2 protein E2-HC, which con-
tains aa 200–365 of HPV16 E2. This E2 protein is able to
bind to DNA and to L1 protein (Fig. 2b), but does not con-
tain the transactivation domain of E2 and therefore should
be severely crippled in its ability to activate the E2-
responsive reporter. Surprisingly, this truncated E2 protein
was able to activate transcription from the synthetic
reporter, but activity was fivefold lower than that of full-
length E2 (Fig. 3c and 3d). Co-transfection of L1 with
E2-HC resulted in a further 10-fold activation of transcrip-
tion, indicating that E2-dependent recruitment of L1 to the
promoter is sufficient for transcriptional enhancement and
that the inherent ability of E2 to function as a transcrip-
tional activator is not necessarily required.
Using a transient DNA replication assay, the effect of L1 on
E2-dependent virus replication was assessed. Cells were trans-
fected with a plasmid containing the viral Ori and E1 or E2
alone or in combination, along with increasing amounts of
the L1 expression plasmid. Protein expression was detected
by Western blotting (Fig. 3e) and replicated Ori-containing
α-2'
α-1'
α-1
α-2
L1
E2
Fig. 1. In silico analysis of potential binding interfaces between HPV16 E2 and L1. In silico modelling was performed using
ZDOCK, ClusPro and Rosetta. Monomeric L1 protein is shown in green and the homodimeric DNA-binding domain of E2 (aa
285–365) in cyan with the region of the a-2 helices (a-2 and a-29) of E2 docked within 4 A˚ of L1 shown in red. The binding
interface with the lowest energy was between an a-2 helix of E2 (aa 335–365) in close proximity to external loops between
aa 250–290 of the L1 protein.
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plasmid was detected by quantitative PCR (qPCR) (Fig. 3f).
As expected, co-expression of E1 andE2 resulted in a dramatic
increase in Ori-dependent replication. This was enhanced by
co-expression of L1 in a dose-dependent manner.
Having demonstrated that the transcription and replication
functions of E2 are stimulated by L1, it was important to
determine whether these effects are due to alterations in
E2 protein stability in the presence of L1. To determine
the half-life of E2 alone or co-expressed with L1, C33a
cells were transfected with E2 and L1 expression plasmids
alone or in combination. Extracts of cells treated with
cycloheximide for 0, 2, 4, 8, 10 and 24 h were analysed
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Fig. 2. Characterization of the HPV16 E2 and L1 interaction. (a) Upper panel: C33a cells were transfected with E2 and L1
expression constructs alone or in combination, and lysates were immunoprecipitated (IP) with sheep anti-E2 or pre-immune
IgG control. Co-immunoprecipitated protein complexes were separated by SDS-PAGE and L1 and E2 proteins were
detected by Western blotting with mouse anti-L1 and anti-E2 (TVG261) antibodies. On the left, 10% input of cell lysates is
shown. Lower panel: C33a cells were transfected with E2 and L1 expression constructs, and lysates were immunoprecipi-
tated with sheep anti-E2 or mouse anti-L1 antibodies and isotype-matched IgG control. Co-immunoprecipitated protein
complexes were separated by SDS-PAGE, and L1 and E2 proteins were detected by Western blotting with mouse anti-L1
and anti-E2 (TVG261) antibodies. On the left, 10% input of cell lysates is shown. A short and a long exposure of the L1 blot
are shown to allow visualization of the protein precipitated with L1- and E2-specific antibodies. (b) GST pull-down assays
using GST, GST-E2 full-length and the truncations indicated in each lane. Upper panel shows a Coomassie-stained gel of
purified GST-E2 proteins, each indicated by *. Middle panels show bound purified L1 capsomeres detected by Western
blotting. On the left, 20% input is shown. This experiment was performed three times and similar results were obtained on
each occasion. A representative Western blot is shown. The scheme in the lower panel represents relative binding affinity of
each E2 truncation. Those that bound L1 are shown in black, those that did not bind are shown in grey. (c) Three-dimensional
image of the dimerized DNA-binding domain of E2 obtained from PDB. The areas shown in black depict the regions of E2
that are important for the interaction with L1. (d) Co-immunoprecipitation assays as described in (a) were performed in the
presence of ethidium bromide (EtBr) to disrupt DNA–protein interactions.
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Fig. 3. L1 co-expression increases E2-dependent transcription activation. (a) C33a cells were co-transfected with an
E2-responsive firefly luciferase reporter (6E2tk), E2 expression plasmid, and increasing amounts of L1 expression plasmid.
E2 and L1 protein levels were determined by Western blotting. Molecular mass standards are indicated on the left.
(b) Luciferase activity in cell lysates was measured and normalized to activity in cells transfected with 6E2-tk-Luc alone.
(c) C33a cells were co-transfected as described in (a) and (d) transcription activity of full-length E2 was compared with a
truncated E2 protein containing aa 200–365 (E2-HC). (d) Luciferase activity was determined as described in (b). (e) C33a
cells were co-transfected with HPV16 Ori plasmid, E2 and E1 expression plasmids and increasing amounts of L1 expression
plasmid. Protein expression was detected by Western blotting. Molecular mass standards are indicated on the left. (f) Dpn I-
digested DNA quantified by qPCR. The data are expressed as fold increase in replication over Dpn I-digested pOri16M
alone. All data shown represent the mean¡SE of three independent experiments. Significance was tested using Student’s t-
test; *P,0.05, **P,0.01, ***P,0.001.
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by Western blotting (Fig. 4a). E2 protein levels were nor-
malized to b-actin protein and used to determine the
half-life of E2 in each experimental condition (Fig. 4b).
It should be noted that an increase in E2 protein expression
was observed following co-expression with L1 protein.
As expression of both of these proteins is driven from a
CMV promoter, we presume that the increase in E2 protein
when co-expressed with L1 is due to the enhancement of
transcription activity of E2, which can enhance CMV pro-
moter activity. This effect was not observed in the tran-
scription assays shown in Fig. 3 because the amount of
plasmid used in the transcription assays was the equivalent
of 10-fold less than the amount used in the stability assays.
The calculated half-life of E2 protein was 4.5 h, which is in
agreement with previous reports (King et al., 2011; Li et al.,
2014). A small increase in the half-life of E2 was observed
in the presence of L1 (5.8 h), but this increase did not reach
significance, suggesting that the effect of L1 on E2 activity is
not due to stabilization of E2. Taken together, these data
provide evidence that L1 directly alters both the transcrip-
tional activation and replication functions of E2.
L1 co-localizes with E2 and prevents nucleolar
accumulation of E2
To further characterize the interaction between E2 and L1,
subcellular localization of these two proteins expressed
alone or in combination was investigated by confocal
microscopy. When expressed alone, E2 protein was local-
ized to the nucleus, and in many cells the staining of
large foci within the nucleus was noted (Fig. 5a). These
E2 foci have been previously reported for HPV1 E2 (Pres-
cott et al., 2014) and were shown to be nucleoli. It has also
been demonstrated that treatment of cells with 100 mM
salt prior to fixation results in strong nucleolar localization
of HPV16 E2 (Sakakibara et al., 2013). To confirm that the
nuclear structures stained with our E2 antibody were
nucleoli, we co-stained E2-transfected cells with an anti-
body specific for a nucleolar marker, C23. Co-localization
of E2 with C23 was observed, demonstrating that E2 loca-
lizes to nucleoli in a subset of transfected cells (Fig. 5b).
Furthermore, we stained cells with a commercially available
mouse monoclonal HPV16 E2-specific antibody and con-
firmed the presence of E2-positive nucleolar staining,
demonstrating that the staining observed with the sheep
polyclonal HPV16 E2 antibody was reproducible (Fig.
5c). When expressed alone, HPV16 L1 was also observed
in the nucleus, but with nucleolar exclusion in the majority
of cells imaged. Of particular note, when E2 and L1 were
co-expressed, the proteins co-localized in the nucleus and
the proportion of cells with nucleolar E2-staining was
significantly reduced (Figs. 5a, d).
E1- and E2-dependent virus genome replication has been
shown to occur in discrete replication factories that form
nuclear foci (Sakakibara et al., 2011, 2013). Owing to its
ability to enhance E2-dependent replication, the local-
ization of L1 protein to E1/E2 replication foci was studied.
As previously described, when co-transfected with the
viral Ori-containing plasmid, E1 and E2 co-localized in
bright foci, which are thought to be replication factories
(Sakakibara et al., 2013) and are distinct from the nucleolar
staining described above. Co-transfection of L1 did
not appear to alter the formation of E1/E2-associated
replication foci and L1 was not enriched within the
replication foci when cells were fixed in formaldehyde
(Fig. 6a). However, extraction of the cells with buffer
containing 100 mM NaCl prior to fixation revealed that a
proportion of L1 protein co-localizes with E1/E2
replication foci, indicating that L1 may stimulate E2-
dependent replication by recruitment to replication
factories (Fig. 6b).
Co-localization of E2 and L1 in differentiating
epithelium
To determine whether the interaction between E2 and L1 is
physiologically relevant, the co-localization of these two
proteins was studied in primary human foreskin keratino-
cytes (HFKs) containing HPV16 episomes. Thirteen-day-
old organotypic rafts were fixed and sections co-stained
with E2 and L1-specific antibodies. E2 staining was
observed in the nucleus and cytoplasm of cells in the
middle and upper layers of the raft section (Fig. 7a).
While some E2-positive cells were stained in both the
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Fig. 4. L1 does not alter E2 protein stability. C33a cells were
transfected with E2 expression vector alone or in combination
with L1. Cells were treated with cycloheximide (CHX) and har-
vested at the stated times. (a) E2 protein levels were determined
by Western blotting and normalized to b-actin levels (detected on
the same membrane). (b) Band intensities were measured using
ImageJ. The data represent the mean¡SE of three independent
experiments.
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nuclear and cytoplasmic compartments [Fig. 7b(i)], some
cells had E2 expression that was predominantly localized
to the nucleus with no obvious cytoplasmic staining
[Fig. 7b(ii)]. As described previously (Xue et al., 2010),
E2 staining in the basal and lower layers of the raft was
not observed, presumably because the amount of E2 pro-
tein expressed in these cells is below the level of detection
(Fig. 7a). No staining was observed in organotypic raft sec-
tions derived from HPV-negative HFKs, demonstrating
specificity of the antibody. Of note, nuclear L1 staining
was observed in individual cells in upper layers of the
raft sections. The nuclei of these cells also stained positive
for E2 [Fig. 7b(iii, iv)]. Some of the L1-positive cells con-
tained distinct E2 foci within the nuclear compartment
that were not observed in L1-negative cells, indicating
that E2 may have a different biological function in differen-
tiated L1-expressing cells. These data provide evidence that
E2 and L1 are co-expressed in a physiologically relevant
model system and that the physical association of these
two viral proteins is likely to play a role in the HPV life
cycle.
DISCUSSION
We predicted that the HPV replication and transcription
factor E2 forms a complex with the late viral capsid protein
L1. We initially tested this hypothesis by mapping potential
interacting surfaces using protein–protein docking algor-
ithms. These studies predicted that the a-2 helices of the
C-terminal DNA-binding domain of E2 associate with L1
loops that lie on the surface of the capsomere knobs. The
position of the predicted binding surface on L1 implies
that E2 could bind to L1 when assembled as a pentameric
capsomere, since the loops predicted to bind to E2 pro-
trude from the surface of the capsomere knobs (Modis
et al., 2002). Interestingly, the region of L1 predicted to
associate with E2 overlaps with the L2 binding region pre-
dicted by Lowe et al. (2008), although since L1 protein is
pentameric in solution, it is possible that L1–L2–E2 com-
plexes could exist. The L1 binding surface within E2 was
predicted to lie within the a-2 helices of the E2 DNA-
binding domain, which is outside the DNA-binding
region contained within the a-1 helices, and was confirmed
by domain-mapping experiments that showed that aa
306–365 of E2 were sufficient for L1 binding. This specific
location of the binding site on E2 suggests that E2 may be
able to bind to L1 and DNA simultaneously. Although
the exact binding interface between L1 and E2 needs
further refinement, an interaction was confirmed by
co-immunoprecipitation experiments in human cervical
keratinocytes. In addition, we showed that the interaction
is not mediated by association with DNA. Interestingly,
E2 and L1 were co-distributed in a subset of cells in the
upper layers of differentiating epithelium in a physiologic-
ally relevant HPV16 life cycle model system.
Characterization of the effect of L1 on E2 activity revealed
that L1 stimulates E2-dependent replication and transcrip-
tion activation, without altering E2 protein stability.
Although the effect of L1 overexpression on E2-dependent
replication was statistically significant, only a 2.5-fold
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Fig. 5. Subcellular localization of HPV16 E2 and L1. Confocal
imaging. (a) C33a cells transfected with E2 and L1 expression
plasmids alone or in combination. E2 protein was stained with
sheep anti-E2 antibody (red) and L1 protein was stained with
mouse anti-L1 antibody (green). DNA was stained with Hoechst
(blue). (b) E2 protein was detected with mouse monoclonal anti-
E2 antibody (TVG261; green). (c) E2 protein was detected with
sheep anti-E2 antibody (red), and nucleolar marker protein C23
is shown in green. Bars (all panels), 10 mm. (d) E2-expressing
cells transfected alone or in combination with L1 were scored for
strong E2-staining in the nucleolus or E2-staining absent from
the nucleolus. At least 80 cells were scored for each experiment.
The data shown represent the mean¡SE of three independent
experiments. Significance was determined using Student’s t-test;
***P,0.001.
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increase in replication was observed. It is possible that this
increased replication is due to alteration of cell cycle pro-
gression of transfected cells, although changes in cellular
proliferation were not noted. It is also possible that the
effect of L1 on E2 activity is enhanced in differentiated
cells, a possibility we are currently testing.
Co-expression of L1 altered the subcellular localization of
E2. When E2 was expressed alone, E2-specific nucleolar
staining was observed in many cells. The localization of
E2 at the nucleolus has not been widely reported, but has
been previously observed in a range of human cell types
in our own immunofluorescence experiments (J.
L. Parish, unpublished) and reported by others for HPV1
E2, or for HPV16 E2 following salt extraction of cells (Pres-
cott et al., 2014; Sakakibara et al., 2013). The function of E2
at the nucleolus is not known, but it is interesting to note
that the Epstein–Barr virus nuclear antigen 1 (EBNA1)
protein, which is functionally analogous to E2, is also
recruited to the nucleolus (Shire et al., 2006). Furthermore,
it has been shown that mutation of dipeptide recognition
motifs of serine-arginine protein kinase 1 (SRPK1) in the
hinge region of HPV1 E2 significantly increases enrichment
of E2 at the nucleolus. HPV1 E1^E4 inhibits SRPK1
activity and enhances nucleolar localization of E2 (Prescott
et al., 2014). Although HPV16 E2 does not contain SRPK1
recognition motifs, it is tempting to speculate that, in the
context of the virus life cycle, the temporal expression of
E1^E4 and L1 could regulate nucleolar localization of E2
as cells terminally differentiate. Further work is required
to understand the function and control of E2 at the nucleo-
lus, but emerging evidence suggests an interplay between
viral and host cell proteins in the regulation of E2 localiz-
ation and activity. Perhaps of greater interest is the obser-
vation that L1 protein partially co-localized with E1/E2
replication factories following salt extraction of cells.
These experiments indicate that a pool of L1 protein is
recruited to replication factories, presumably to enhance
virus replication.
The mechanistic regulation of E2 activity in the context of
the virus life cycle is not understood. However, character-
ization of the interaction with L1 and other viral proteins
demonstrates the ability of the virus to self-regulate E2
activity in differentiating epithelium (Fig. 8). Association
of E2 with E1 in the basal cells is important for viral
genome replication (Sanders & Stenlund, 2001), while
association with the E6 and E7 proteins appears to regulate
oncoprotein activity (Gammoh et al., 2006; Grm et al.,
2005). In addition, E6 appears to inhibit E2-dependent
virus replication (Grm et al., 2005). Differentiation-
induced expression of E1^E4 in the mid-layers of the epi-
thelium results in a stabilization of E2 (Davy et al., 2009),
which is consistent with the observed increased expression
of E2 in the mid- and upper layers of cervical epithelia
(Xue et al., 2010) and organotypic raft cultures of
HPV16-positive primary HFKs (Fig. 7). Whether E2 is
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Fig. 6. L1 protein is recruited to E1/E2 replication factories. (a) C33a cells were transfected with the Ori-containing
plasmid, E1 and E2 (upper panel), and co-transfected with an L1 expression plasmid (lower panel). E2 protein was stained
with sheep anti-E2 antibody (red), E1 with rabbit anti-HA antibody (green) and L1 with mouse anti-L1 antibody (magenta).
DNA was stained with Hoechst (blue). (b) Cells were transfected as described for (a) and extracted with 100 mM NaCl prior
to fixation as described in Methods. Images were captured by confocal microscopy. Bars, 10 mm.
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able to simultaneously interact with E1^E4 and L1 in dif-
ferentiated cells remains to be determined.
Our data show that L1 enhances E2-dependent virus repli-
cation and, following salt extraction of cells, we observed
that L1 protein co-localizes with E1/E2 replication foci in
the presence of viral origin of replication. Put together
with the observation that E2 and L1 proteins are co-
expressed in HPV16-genome-containing differentiating
epithelium, it is possible that L1 contributes to E2-
dependent viral genome amplification in the late stages of
the virus life cycle. We also demonstrate that L1 co-
expression increases transcription from an E2-responsive
reporter. This is somewhat surprising since E2 is thought
to switch from a transcriptional activator to a repressor
as E2 levels rise in differentiating epithelium, resulting in
repression of the E6 and E7 oncoproteins and subsequent
cell cycle exit (Thierry, 2009). However, our experiments
were performed using a synthetic E2-responsive promoter,
which is a useful assay in the measurement of E2 activity in
transfected cell systems such as that used in this study, but
does not truly reflect the function of E2 as a transcriptional
regulator at the viral long control region in differentiating
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E2 L1 DNA E2/L1/DNA
Fig. 7. L1 and E2 co-localize in differentiating epithelium. (a) Sections of organotypic raft cultures derived from primary HFKs
or HPV16-genome-containing HFKs from the same donor were stained with rabbit anti-E2 antibody (Xue et al., 2010) (red)
and mouse anti-L1 antibody (green) and DNA-stained with Hoechst (blue). The basal cells in each panel are highlighted by
the dotted line. Bar, 10 mm. (b) Enlarged images highlight E2-positive, L1-negative cells with strong cytoplasmic and nuclear
staining (i) and nuclear staining (ii). L1- and E2-positive cells show nuclear L1- and E2-staining (iii) and nuclear L1-staining
with distinct E2 foci (iv). Bar, 5 mm.
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epithelium. It is also conceivable that E2 and L1 do not act
synergistically on the synthetic promoter and that the
enhancement of transcription observed is not a direct
result of the E2–L1 protein–protein interaction but an
additive effect of independent promoter stimulation by
E2 and L1. Nonetheless, the enhancement of E2 activity
by L1 is intriguing and is likely to contribute to the self-
regulation of E2 throughout the virus life cycle. It is also
possible that the interaction between L1 and E2 does not
regulate E2 activity in the context of the HPV life cycle,
but plays a role in an as yet understudied step in the life
cycle, such as the formation of virus particles. Finally, in
the upper layers of the epithelium, L2 expression is
initiated, which inhibits E2-dependent replication and
facilitates virus genome packaging (Day et al., 1998).
In summary, the differential regulation of E2 activity by
early and late viral proteins appears to allow the use of a
single viral protein to support multiple important life
cycle events. Our data provide evidence of an interaction
between E2 and the capsid protein L1, further adding to
the complexity of E2 regulation during late stages of the
virus life cycle.
METHODS
In silico protein interaction analysis. Potential interactions
between HPV16 L1 and E2 were computationally analysed using
multiple-docking programs. The protein database (PDB) coordinate
files for HPV16 L1 (1DZL) (Modis et al., 2002) and HPV16 E2-DNA-
binding domain (1ZZF) were used and protein–protein interactions
were predicted using ZDOCK 3.0.2 (http://zdock.umassmed.edu)
(Pierce et al., 2014), ClusPro (http://cluspro.bu.edu) (Comeau et al.,
2004) and Rosetta (Lyskov & Gray, 2008).
Cell culture. C33a (human cervical carcinoma epithelial) cells were
grown in Dulbecco’s modified Eagle’s medium containing 10% FBS at
37 uC, 5% CO2, using standard tissue culture techniques. The trans-
fection of primary HFKs from neonatal foreskin epithelia (ethical
approval number 06/Q1702/45) was performed in Dr S. Roberts’
laboratory as previously described (Wilson et al., 2007). A plasmid
containing the wild-type HPV16 114 kb genome (obtained from Ethel-
Michele de Villiers, DKFZ, Germany) was digested with BamHI and
recircularized and transfected into early-passage primary HFKs with a
neomycin resistance marker. Twenty-four hours later, cells were seeded
onto irradiated J2-3T3 fibroblasts in the presence of G418 in Emedium
(Wilson & Laimins, 2005) for 8 days. Emerging colonies were pooled
and the presence of episomal HPV16 genomes was determined by
Southern blotting (C. D. James and S. Roberts, unpublished data).
Organotypic raft cultures were prepared as previously described
(Wilson & Laimins, 2005) and cultured for 13 days. Rafts were fixed
in 3.7% paraformaldehyde and paraffin-embedded prior to sectioning
(Propath).
Plasmids. pUF3-16L1h expresses codon-optimized HPV16 L1 from a
CMV promoter obtained fromMartin Mu¨ller, DKFZ, Germany (Leder
et al., 2001). pJ4V16E2 expresses HPV16 E2 from a CMV promoter
(Bouvard et al., 1994). Haemagglutinin (HA)-tagged HPV16 E1 was
expressed from plasmid pHPV16-E1HA, obtained from Mart Ustav,
Estonain Biocentre, Estonia. p6E2-tk-Luc contains six E2 binding sites
upstream of a thymidine kinase promoter which drives firefly luciferase
expression (Vance et al., 1999). pOri16M was obtained from Iain
Morgan, University of Virginia, USA, and contains a modified HPV16
Ori (nt 7838–139) (Taylor & Morgan, 2003). GST-fused HPV16 E2
truncations were expressed from pGEX2T constructs obtained from
Professor Lawrence Banks, ICGEB, Trieste (Gammoh et al., 2006;
Johansson et al., 2012), with the exception of GST-E2 306–365, which
was constructed by ligation of a PCR product encoding these amino
acids into the BamHI and EcoRI sites of pGEX4T-1.
Antibodies. HPV16 E2was detected with either affinity-purified sheep
anti-HP V16 E2 antibody which was produced by immunization with
bacterially expressed and purified hexahistidine-tagged HPV16 E2
N-terminal domain (aa 1–216; Dundee Cell Products), mouse anti-
HPV16 E2 TVG261 (Abcam) or affinity-purified rabbit polyclonal
anti-HPV16 E2 antibody (obtained from Franc¸oise Thierry, Institute of
Medical Biology, Singapore) (Xue et al., 2010). L1 was detected with
mouse anti-HPV16 L1 antibody (Abcam). Mouse anti-HA antibody
12CA5 (Sigma-Aldrich) and rabbit anti-HA antibody HA.11 (Abcam)
were used to detect HA-tagged HPV16 E1. Non-specific rabbit and
mouse IgGs were purchased from Santa Cruz Biotechnology.
Mouse anti-b-actin was purchased from Sigma-Aldrich. Horseradish
peroxidase-conjugated secondary antibodies were used for Western
blotting (Thermo Scientific). Alexa-Fluor-conjugated secondary
antibodies were used for immunofluorescence (Invitrogen).
Co-immunoprecipitation. C33a cells (3|106) were seeded into
10 cm dishes and transfected using X-tremeGENE 9 (Roche). Co-
immunoprecipitations were performed as previously described (Parish
et al., 2006b).
GST pull-down. GST fusion proteins were purified from bacteria
induced with 0.5 M IPTG for 4 h at 37 uC. Bacteria were lysed
(25 mM Tris/HCl pH 8.0, 250 mM NaCl, protease inhibitors, 5 mM
DTT) and samples were sonicated for 30 s at 30% amplitude. Cleared
lysates were incubated with glutathione agarose slurry at 4 uC for
2–6 h with gentle agitation. The beads were washed in lysis buffer and
bound proteins were separated by SDS-PAGE and Coomassie-stained.
For binding assays, equal amounts of GST fusion proteins (assessed
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by SDS-PAGE) immobilized on resin were incubated with 50 ng
CsCl-purified L1 capsomeres obtained from Professor Martin
Muller, DKFZ, Germany (Tho¨nes et al., 2008). Binding buffer
(200 ml; 50 mM Tris/HCl pH 7.4, 100 mM KCl, 0.1 mM EDTA, 0.2%
NP-40, 0.1% BSA, 2.5% glycerol) was added and the samples were
incubated at 4 uC for 2 h with gentle agitation. Samples were washed
extensively (100 mM Tris/HCl pH 7.4, 150 mM NaCl, 1% NP-40,
200 mM KCl) and bound L1 protein was detected by Western
blotting.
Transcription assay. Transcription assays were performed as pre-
viously described (Feeney et al., 2011). C33a cells (3|105) were
seeded into each well of a six-well plate and co-transfected with ex-
pression plasmids for E2 (50 ng) and L1 (100, 250, 500 ng) along with
luciferase reporter plasmid p6E2-tk-Luc (100 ng). Firefly luciferase
activity was determined by luciferase assay (Promega).
Replication assay. C33a cells (2.5|105) were seeded into each well
of a six-well plate and left to adhere overnight. Cells were then co-
transfected with 25 ng pOri16M, expression plasmids for L1 (100,
250, 500 ng), E2 (10 ng) and E1 (600 ng). Salmon sperm DNA was
included to normalize the DNA amount in each transfection. Forty-
eight hours later, cells were washed in PBS and DNA extracted using
250 ml Hirt extraction buffer (0.6% SDS, 10 mM EDTA). NaCl was
added to a final concentration of 1.25 M, and samples were incubated
overnight at 4 uC. The DNA was purified by phenol/chloroform/
isoamyl alcohol extraction followed by ethanol precipitation, and the
DNA pellet was resuspended in 20 ml water. DNA was digested with
Dpn I at 37 uC for 4 h and replicated pOri16M was measured by qPCR
using Sensimix SyBr (Bioline) and an MXPro3005 PCR machine
(Agilent) as previously described (Taylor & Morgan, 2003).
Immunofluorescence. C33a cells were seeded onto glass coverslips
prior to transfection with Lipofectamine 2000 (Invitrogen). All sub-
sequent incubations were performed at room temperature. Twenty-
four hours post-transfection, cells were fixed with 4% formaldehyde
for 10 min and permeabilized in 0.2% Triton X-100/PBS for 10 min.
Immunofluorescent staining of HFK raft sections was performed
following an agitated low-temperature antigen retrieval as previously
described (Watson et al., 2002). Cells were blocked (10% heat-inacti-
vated goat serum, 2% BSA in PBS) for 1 h and stained as previously
described (Parish et al., 2006a). Epifluorescent imaging was performed
on a Nikon E600 epifluorescent microscope fitted with a DXM1200F
digital camera, and confocal images were captured on a Zeiss LSM 510
META confocal microscope.
Protein stability assays. C33a cells (6|106) were seeded in 15 cm
dishes and transfected with X-TremeGENE 9 (Roche). Twenty-four
hours later, cells were trypsinized, and counted, and 1|106 cells were
reseeded in 6 cm dishes. The following day, cells were treated with
10 mg ml21 cycloheximide (Sigma) and harvested at 0, 2, 4, 8, 10 and
24 h, lysed in urea lysis buffer (50 mM Tris/HCl, pH 7.4, 9 M urea,
5 mM DTT) and sonicated for 15 s at 30% amplitude. Protein con-
centration was quantified by Bradford assay and proteins detected by
Western blotting. Relative amounts of proteins at each time point
were quantified and normalized to b-actin using ImageJ software, and
half-life was calculated using Graphpad Prism 4 software using a one-
phase exponential decay model.
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